Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.

Supporting you

We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years. 

Find out more about the MS-UK Helpline

Find out more about our Choices booklets

Find out more about New Pathways magazine

 


According to a new study of more than 5,000 people, late 30s might be a critical time to start drug therapy to halt the progression of multiple sclerosis (MS). Researchers told the 35th Congress of...
Researchers have identified three genes that play a role in vision loss in multiple sclerosis (MS), possibly paving the way for the development of precision medicine for the condition. The study by...
Stem cell treatment for people living with multiple sclerosis (MS) in Scotland has been recommended on the NHS for the first time. The Scottish Health Technologies Group, which provides evidence and...
Higher intelligence and physical exercise in childhood may help slow the development of cognitive impairment in people with multiple sclerosis (MS), a study has found. The research, which was...
The Sapphire Medical Clinic in London this month became the first in the UK to be approved by the Care Quality Commission (CQC) to prescribe medical cannabis. The UK government legalised cannabis-...
Working night shifts for many years increases a person’s risk for multiple sclerosis (MS), a new study has found. Published in the journal Occupational and Environmental medicine, the study found...
Sainsbury’s and Argos have announced the nationwide rollout of sunflower lanyards in all stores, to help customers with hidden disabilities. Following a successful trial earlier this year, the scheme...
A new report has found that people with multiple sclerosis (MS) are more likely to have certain other health conditions than the overall population. The study, The Health Impact of Multiple Sclerosis...
Public awareness of multiple sclerosis (MS) is set for a boost this week thanks to a new campaign from the MS Society. A television advert starring people living with the condition aired last night...
A new drug has shown promising results in a phase three trial for relapsing remitting multiple sclerosis (RRMS). Ponesimod significantly reduced relapse rate, new active lesions and fatigue when...

Pages